National Toxicology Program

National Toxicology Program

Scientific Review of Tamoxifen

CASRN 10540-29-1
Status: Listed in the Report on Carcinogens (RoC)

Primary Uses or Exposures: Tamoxifen is used as an anti-estrogen drug in the palliative treatment of breast cancer and to reduce the incidence of breast cancer in women at high risk of this disease.

Background Document

Public Comments


Note on Accessibility: Persons with disabilities or using assistive technology may find some documents are not fully accessible. For assistance, contact Central Data Management or call 919-541-3419 and identify the documents/pages for which access is required. We will assist you in accessing the content of these files. NIEHS has helpful information on accessibility.

NTP is located at the National Institute of Environmental Health Sciences, part of the National Institutes of Health.